Hopkinson Craig C.

EVP R&D, Chief Medical OfficerAlkermes plc. (ALKS) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$464K
Net Open-Market Flow
-$464K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)5K$19.34$97K82K
Jul 1, 2026Sell(S)8K$51.46$427K74K
Jul 1, 2026Sell(S)700$52.13$36K73K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)5K$01K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001520262-26-000103) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.